Sanofi allies with OpenAI, Formation Bio for AI use in drug development / Photo: © AFP/File
-
New-look Australia focused on LA 2028 at swimming worlds
-
China urges global consensus on balancing AI development, security
-
David's century sparks Aussies to T20I clincher over WIndies
-
Death toll rises in Thai-Cambodian clashes despite ceasefire call
-
China prodigy takes on swimming world aged 12
-
UN gathering eyes solution to deadlocked Palestinian question
-
Polls open in Taiwan's high-stakes recall election
-
'Alien' lands at Comic-Con
-
Top footballers afraid to speak out against playing too many games: FIFPro chief
-
Top US Justice official questions Epstein accomplice for 2nd day
-
Cambodia calls for ceasefire with Thailand: envoy to UN
-
Raducanu and Fernandez beat the heat to reach DC Open semis
-
US stocks end at records as markets eye tariff deadline
-
Trump, EU chief to meet Sunday in push for trade deal
-
Fake AI photos of Trump with Epstein flood internet
-
Ponting says 'no reason' why Root cannot top Tendulkar's run record
-
NFL players, employees fined for selling Super Bowl tickets: reports
-
World's smallest snake makes big comeback
-
Trade on agenda as Trump lands in Scotland for diplomacy and golf
-
UN chief blasts 'lack of compassion' for Palestinians in Gaza
-
Trump administration expected to say greenhouse gases aren't harmful
-
Hamilton suffers unprecedented spinning knockout in Belgian GP sprint qualifying
-
European powers urge end to Gaza 'humanitarian catastrophe'
-
Messi, Alba suspended over MLS All-Star no-show: league
-
RB's Permane returns as team boss at Belgian GP two years after sacking
-
Trump says '50/50 chance' of US-EU trade deal
-
Top US Justice official meets with Epstein accomplice for 2nd day
-
Mekies makes retaining Verstappen his Red Bull priority
-
Pogacar exits Alps with Tour stranglehold as Arensman edges white-knuckle win
-
Piastri takes pole for Belgian GP sprint race ahead of Verstappen
-
UK, France, Germany say Gaza 'humanitarian catastrophe must end now'
-
Stock markets mark time as Trump puts EU-US trade deal at 50/50
-
Pogacar exits Alps with Tour stranglehold as Arensman takes stage
-
France defends move to recognise Palestinian state
-
Trade on agenda as Trump heads to Scotland for diplomacy and golf
-
France's top court annuls arrest warrant against Syria's Assad
-
How might Trump's tariffs hurt Brazil?
-
Rubiales forced kiss could drive Spain on in Euro 2025 final: England's Toone
-
Trump says Hamas 'didn't want' Gaza deal as talks break down
-
Tour de France prankster gets eight-month suspended term for crossing finish line
-
Root climbs to second on all-time Test list as England dominate India
-
Stock markets stall as Trump puts EU-US trade deal at 50/50
-
UK starts online checks to stop children accessing harmful content
-
Root up to third on all-time Test list as England dominate India
-
Piastri outpaces Verstappen in opening practice at Belgian GP
-
Cambodian evacuees sheltering in temple pray for end to Thai clashes
-
French car dealer charged over Takata air bag injury
-
Iran meets European powers amid threats of UN sanctions snapback
-
Meta to ban political ads in EU due to bloc's 'unworkable' rules
-
UN urges UK to repeal 'disproportionate' Palestine Action ban
NYSE - LSE
| SCU | 0% | 12.72 | $ | |
| CMSD | 0.17% | 22.89 | $ | |
| JRI | -0.46% | 13.09 | $ | |
| SCS | 0.66% | 10.58 | $ | |
| RBGPF | -1.52% | 73.88 | $ | |
| NGG | -0.11% | 72.15 | $ | |
| BCE | -0.95% | 24.2 | $ | |
| RIO | -1.16% | 63.1 | $ | |
| GSK | -0.68% | 37.97 | $ | |
| BCC | 1.94% | 88.14 | $ | |
| AZN | -1.4% | 72.66 | $ | |
| CMSC | 0.24% | 22.485 | $ | |
| RELX | -1.86% | 52.73 | $ | |
| VOD | -0.79% | 11.43 | $ | |
| BP | 0.22% | 32.2 | $ | |
| RYCEF | -0.3% | 13.2 | $ | |
| BTI | -0.71% | 52.25 | $ |
Sanofi allies with OpenAI, Formation Bio for AI use in drug development
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs.
AI is playing an ever greater role in developing new medicines, as well as identifying new applications for existing drugs.
It can be used for example to find new molecules more quickly and to improve clinical tests by vetting which patients would be most likely to respond to treatments.
By combining their resources, the three companies "can reimagine drug development in the pharma industry," said Benjamine Liu, chief executive of Formation Bio.
Sanofi has in recent years cooperated on AI with biotechnology companies such as Owkin, Exscientia, Insilico Medicine, Amunix Pharmaceuticals, Atomwise and Aqemia.
In a statement, Sanofi said: "The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle."
"Sanofi will leverage this partnership to provide access to proprietary data to develop AI models as it continues on its path to becoming the first biopharma company powered by AI at scale," it said.
OpenAI "will contribute access to cutting-edge AI capabilities, including the ability to fine-tune models, deep AI expertise and dedicated thought partnership and resources."
B.Baumann--VB